249 related articles for article (PubMed ID: 16625520)
1. Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data.
Mogg R; Mehrotra DV
Stat Med; 2007 Feb; 26(3):484-97. PubMed ID: 16625520
[TBL] [Abstract][Full Text] [Related]
2. [Immune-based therapies and HIV infection].
Weiss L
Ann Med Interne (Paris); 2002 Jun; 153(4):227-36. PubMed ID: 12218888
[TBL] [Abstract][Full Text] [Related]
3. Treatment comparisons for a partially categorical outcome applied to a biomarker with assay limit.
Chen YH; Gould AL; Nessly ML
Stat Med; 2005 Jan; 24(2):211-28. PubMed ID: 15558832
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
5. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I;
J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy and therapeutic vaccines in HIV infection.
García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
[TBL] [Abstract][Full Text] [Related]
7. Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial.
Boffito M; Fox J; Bowman C; Fisher M; Orkin C; Wilkins E; Jackson A; Pleguezuelos O; Robinson S; Stoloff GA; Caparrós-Wanderley W
Vaccine; 2013 Nov; 31(48):5680-6. PubMed ID: 24120550
[TBL] [Abstract][Full Text] [Related]
8. On the analysis of viral load endpoints in HIV vaccine trials.
Hudgens MG; Hoering A; Self SG
Stat Med; 2003 Jul; 22(14):2281-98. PubMed ID: 12854093
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune.
Angel JB; Routy JP; Tremblay C; Ayers D; Woods R; Singer J; Bernard N; Kovacs C; Smaill F; Gurunathan S; Sekaly RP
AIDS; 2011 Mar; 25(6):731-9. PubMed ID: 21330911
[TBL] [Abstract][Full Text] [Related]
10. Estimating cumulative probabilities from incomplete longitudinal binary responses with application to HIV vaccine trials.
Hudgens MG
Stat Med; 2003 Feb; 22(3):463-79. PubMed ID: 12529875
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
12. A boost for the immune system.
TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
[TBL] [Abstract][Full Text] [Related]
13. Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiation.
Gilbert PB; Sun Y
Biostatistics; 2005 Jul; 6(3):374-94. PubMed ID: 15831584
[TBL] [Abstract][Full Text] [Related]
14. Remune trial will stop; new trials planned.
James JS
AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
[TBL] [Abstract][Full Text] [Related]
15. Trial suggests vaccines could aid HIV therapy.
Check E
Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722
[No Abstract] [Full Text] [Related]
16. Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.
Messer K; Vaida F; Hogan C
Contemp Clin Trials; 2006 Dec; 27(6):506-17. PubMed ID: 16962381
[TBL] [Abstract][Full Text] [Related]
17. Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies.
Angel JB
AIDS Read; 2001 Apr; 11(4):209-21. PubMed ID: 11392678
[TBL] [Abstract][Full Text] [Related]
18. A multiple imputation method for missing covariates in non-linear mixed-effects models with application to HIV dynamics.
Wu H; Wu L
Stat Med; 2001 Jun; 20(12):1755-69. PubMed ID: 11406839
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
20. Chop-lump tests for vaccine trials.
Follmann D; Fay MP; Proschan M
Biometrics; 2009 Sep; 65(3):885-93. PubMed ID: 19210727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
